Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Assets

    Back to Balance Sheet
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Assets ₹5,630 Cr₹5,881 Cr₹6,840 Cr₹7,115 Cr₹6,709 Cr

What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹5,630 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Assets
Mar2025₹5,630 Cr
Mar2024₹5,881 Cr
Mar2023₹6,840 Cr
Mar2022₹7,115 Cr
Mar2021₹6,709 Cr

How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Assets % Change
Mar2025 ₹5,630 Cr
-4.27
Mar2024 ₹5,881 Cr
-14.03
Mar2023 ₹6,840 Cr
-3.86
Mar2022 ₹7,115 Cr
6.04
Mar2021 ₹6,709 Cr -

Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,037.0 Cr 2.8% 2.2% 40.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.8%

2.2%

40.6%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses